Extracellular vesicles and oncogenic signaling

In recent years, extracellular vesicles (EVs) emerged as potential diagnostic and prognostic markers for cancer therapy. While the field of EV research is rapidly developing and their application as vehicles for therapeutic cargo is being tested, little is still known about the exact mechanisms of s...

Full description

Bibliographic Details
Main Authors: Antonia Schubert, Michael Boutros
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Molecular Oncology
Subjects:
Online Access:https://doi.org/10.1002/1878-0261.12855
id doaj-270f3b5e2a4e4da28babf47120c274f8
record_format Article
spelling doaj-270f3b5e2a4e4da28babf47120c274f82021-09-23T16:15:29ZengWileyMolecular Oncology1574-78911878-02612021-01-0115132610.1002/1878-0261.12855Extracellular vesicles and oncogenic signalingAntonia Schubert0Michael Boutros1Division Signaling and Functional Genomics German Cancer Research Center (DKFZ) and Heidelberg University GermanyDivision Signaling and Functional Genomics German Cancer Research Center (DKFZ) and Heidelberg University GermanyIn recent years, extracellular vesicles (EVs) emerged as potential diagnostic and prognostic markers for cancer therapy. While the field of EV research is rapidly developing and their application as vehicles for therapeutic cargo is being tested, little is still known about the exact mechanisms of signaling specificity and cargo transfer by EVs, especially in vivo. Several signaling cascades have been found to use EVs for signaling in the tumor–stroma interaction. These include potentially oncogenic, verbatim transforming, signaling cascades such as Wnt and TGF‐β signaling, and other signaling cascades that have been tightly associated with tumor progression and metastasis, such as PD‐L1 and VEGF signaling. Multiple mechanisms of how these signaling cascades and EVs interplay to mediate these complex processes have been described, such as direct signal activation through pathway components on or in EVs or indirectly by influencing vesicle biogenesis, cargo sorting, or uptake dynamics. In this review, we summarize the current knowledge of EVs, their biogenesis, and our understanding of EV interactions with recipient cells with a focus on selected oncogenic and cancer‐associated signaling pathways. After an in‐depth look at how EVs mediate and influence signaling, we discuss potentially translatable EV functions and existing knowledge gaps.https://doi.org/10.1002/1878-0261.12855exosomesextracellular vesiclesmetastasismicrovesiclessignalingtumor progression
collection DOAJ
language English
format Article
sources DOAJ
author Antonia Schubert
Michael Boutros
spellingShingle Antonia Schubert
Michael Boutros
Extracellular vesicles and oncogenic signaling
Molecular Oncology
exosomes
extracellular vesicles
metastasis
microvesicles
signaling
tumor progression
author_facet Antonia Schubert
Michael Boutros
author_sort Antonia Schubert
title Extracellular vesicles and oncogenic signaling
title_short Extracellular vesicles and oncogenic signaling
title_full Extracellular vesicles and oncogenic signaling
title_fullStr Extracellular vesicles and oncogenic signaling
title_full_unstemmed Extracellular vesicles and oncogenic signaling
title_sort extracellular vesicles and oncogenic signaling
publisher Wiley
series Molecular Oncology
issn 1574-7891
1878-0261
publishDate 2021-01-01
description In recent years, extracellular vesicles (EVs) emerged as potential diagnostic and prognostic markers for cancer therapy. While the field of EV research is rapidly developing and their application as vehicles for therapeutic cargo is being tested, little is still known about the exact mechanisms of signaling specificity and cargo transfer by EVs, especially in vivo. Several signaling cascades have been found to use EVs for signaling in the tumor–stroma interaction. These include potentially oncogenic, verbatim transforming, signaling cascades such as Wnt and TGF‐β signaling, and other signaling cascades that have been tightly associated with tumor progression and metastasis, such as PD‐L1 and VEGF signaling. Multiple mechanisms of how these signaling cascades and EVs interplay to mediate these complex processes have been described, such as direct signal activation through pathway components on or in EVs or indirectly by influencing vesicle biogenesis, cargo sorting, or uptake dynamics. In this review, we summarize the current knowledge of EVs, their biogenesis, and our understanding of EV interactions with recipient cells with a focus on selected oncogenic and cancer‐associated signaling pathways. After an in‐depth look at how EVs mediate and influence signaling, we discuss potentially translatable EV functions and existing knowledge gaps.
topic exosomes
extracellular vesicles
metastasis
microvesicles
signaling
tumor progression
url https://doi.org/10.1002/1878-0261.12855
work_keys_str_mv AT antoniaschubert extracellularvesiclesandoncogenicsignaling
AT michaelboutros extracellularvesiclesandoncogenicsignaling
_version_ 1717370337915568128